Crosslink between mutations in mitochondrial genes and brain disorders: implications for mitochondrial-targeted therapeutic interventions
Open Access
- 1 January 2023
- journal article
- review article
- Published by Medknow in Neural Regeneration Research
- Vol. 18 (1) , 94-101
Abstract
G mechanisms involved in these neurological disorders. Mitochondrial genetics, defects in mitochondrial oxidative phosphorylation machinery, and reactive oxygen species production might share common crosstalk in the progression of these neurological disorders. It is of significant interests to explore and develop therapeutic strategies aimed at correcting mitochondrial abnormalities. This review provided insights on mitochondrial dysfunction/mutations involved in the progression of Alzheimer’s disease, Huntington’s disease, and epilepsy with a special focus on Parkinson’s disease pathology. Along with the deleterious effects of mitochondrial mutations in aforesaid neurological disorders, this paper unraveled the available therapeutic strategy, specifically aiming to improve mitochondrial dysfunction, drugs targeting mitochondrial proteins, gene therapies aimed at correcting mutant mtDNA, peptide-based approaches, and lipophilic cations....Keywords
This publication has 121 references indexed in Scilit:
- Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson diseaseFree Radical Biology and Medicine, 2013
- Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's diseaseEMBO Molecular Medicine, 2012
- Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activityNature Medicine, 2011
- POLG1 polyglutamine tract variants associated with Parkinson's diseaseNeuroscience Letters, 2010
- A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's diseaseThe Pharmacogenomics Journal, 2009
- Antioxidants and free radical scavengers do not consistently delay seizure onset in animal models of acute seizuresEpilepsy & Behavior, 2008
- Chemical Inhibition of the Mitochondrial Division Dynamin Reveals Its Role in Bax/Bak-Dependent Mitochondrial Outer Membrane PermeabilizationDevelopmental Cell, 2008
- Mitochondrial Medicine: Pharmacological targeting of mitochondria in diseaseBritish Journal of Pharmacology, 2007
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998